Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A high-concentration GLP-1 receptor agonist for research into glycemic control, appetite suppression, and long-term metabolic health
The Case for Injections Injectable tirzepatide is administered once every seven days
You probably landed here after cortisol, perimenopause, or a decade of failed diets pushed you toward a GLP-1 like Wegovy or Zepbound
Comparison of Ozempic and Wegovy (Semagluitide) with Mounjaro (Tirzepatide) *API=Active pharmaceutical ingredient Side effects of tirzepatide Like the other weight loss drugs, the use of tirzepatide is also not free from side effects
MON-VL-0003-IFU-20260422 This Instructions for Use has been approved by the U.S
